All In MedTech

FDA Clearance Tracker · P140033-S100

Tendril™ MRI Pacing Leads / Assurity MRI, Endurity MRI, Zenex MRI, Zenus MRI Pacemakers

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Nov 20, 2025 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

Nov 20, 2025

Approved

Time to decision

71 days

Received Sep 10, 2025. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Normal 180 Day Track

Device class

Class III

The decision

FDA number
P140033-S100
Device name
Tendril™ MRI Pacing Leads / Assurity MRI, Endurity MRI, Zenex MRI, Zenus MRI Pacemakers
Applicant location
Sylmar, CA
Received
Sep 10, 2025
Decided
Nov 20, 2025
Decision
Approved
Supplement type
Normal 180 Day Track
Reason for supplement
Labeling Change - Indications/instructions/shelf life/tradename
Original approval
P140033

Device type

Device class
Class III

Every decision under product code LWP

FDA's approval statement

As written in FDA's record.

approval for model line extensions for the Zenex™ MRI & Zenus™ MRI families of pacemakers and updated labeling for cardiac leads and additional pacemaker models

Source documents

Other decisions for ABBOTT MEDICAL

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

7 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.